Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

In addition diabetes can be treated and its consequences avoided or delayed with medication, regular screening and treatment for complications. In 2007 General Assembly adopted resolution 61/225 ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...